ProCE Banner Activity

Incorporating Immune Checkpoint Inhibitors Into Treatment For Patients With HCC

Slideset Download
Download this slideset for expert perspectives on current best practices and emerging strategies in immune checkpoint inhibitor therapy for patients with advanced HCC.

Released: January 23, 2020

Expiration: January 21, 2021

Share

Faculty

Andrew X. Zhu

Andrew X. Zhu, MD, PhD, FACP

Director, Liver Cancer Research
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Eisai

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Andrew X. Zhu, MD, PhD, FACP

Director, Liver Cancer Research
Massachusetts General Hospital Cancer Center
Boston, Massachusetts